Historical annual and monthly returns for Pfizer (PFE).
For Pfizer (PFE), the strongest completed calendar year was 2021, when the stock returned 66.7%, while its weakest was 2023, with a return of -41.2%. Across the 26 completed calendar years from 2000 through 2025, its average annual return was 5.2% and its compounded annual return was 2.9%. PFE posted positive returns in 16 of those 26 years (62%). In 2025, the latest completed year, it returned 0.7%. In 2026 year to date, PFE has returned 21.2%.
Returns are calculated from the adjusted daily closing prices for Pfizer (PFE). Annual returns measure the percentage change between the final available trading prices of consecutive calendar years. Monthly returns use the corresponding month-end observations. Adjusted prices account for stock splits and distributions when supplied by the market-data provider. Results are nominal and are not adjusted for inflation.
